awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34608366-08CAC6D5-CF06-4864-BB61-DE374742751C
Q34608366-08CAC6D5-CF06-4864-BB61-DE374742751C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34608366-08CAC6D5-CF06-4864-BB61-DE374742751C
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
P2860
Q34608366-08CAC6D5-CF06-4864-BB61-DE374742751C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34608366-08CAC6D5-CF06-4864-BB61-DE374742751C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e5db76cc00a0a78e9bd2c8919f9fd9b2426666aa
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.